Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prograf vs Envarsus in Liver Transplant Recipients
NCT05655273Phase 4Enrolling by invitation
- Sponsor
- University Health Network
- Start
- Jan 2024
- Primary completion
- Apr 2025
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection, sponsored by University Health Network. Started Jan 2024; status: enrolling by invitation.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT05655273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05655273.